Repligen

Repligen

Repligen

Nearly all therapeutic monoclonal antibodies (mAbs) on the market or in development are produced using bioprocessing products manufactured by Repligen
Founded
1981
Raised
$4M
Follow us
Alexa global traffic share
Twitter followers
Latest funding
$4,000,000
Venture capital - 2014
Team Size
50+
Employees
The Motley Fool

Read This Before You Sell Repligen Corporation Stock

The Motley Fool

Repligen Corporation Jumped 14.6% in February -- Here's Why

The Motley Fool

Why Repligen Corporation Shares Are Falling --